Elsbernd Brian bought CPRX
September 8, 2025 · Form 4 insider transaction
Elsbernd Brian bought 112,475 shares of Catalyst Pharmaceuticals Inc at $2.24 per share, a transaction worth $251.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
112,475
Price
$2.24
Total value
$251.9K
InsiderElsbernd Brian
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeM: Option exercise
Transaction dateSeptember 8, 2025
Filing dateSeptember 10, 2025
Shares owned after301,039
OwnershipDirect
10b5-1 planNo
AmendedNo